Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
3.500
-0.050 (-1.41%)
At close: Oct 10, 2025, 4:00 PM EDT
3.499
-0.001 (-0.03%)
After-hours: Oct 10, 2025, 7:48 PM EDT
Nuwellis Revenue
Nuwellis had revenue of $1.73M in the quarter ending June 30, 2025, a decrease of -21.38%. This brings the company's revenue in the last twelve months to $8.32M, down -7.72% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.
Revenue (ttm)
$8.32M
Revenue Growth
-7.72%
P/S Ratio
0.03
Revenue / Employee
$218,895
Employees
38
Market Cap
3.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
Dec 31, 2013 | 59.00K | - | - |
Dec 31, 2012 | - | - | - |
Dec 31, 2011 | - | - | - |
Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NUWE News
- 11 days ago - Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® - GlobeNewsWire
- 23 days ago - Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration - GlobeNewsWire
- 24 days ago - Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment - GlobeNewsWire
- 4 weeks ago - Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio - GlobeNewsWire
- 5 weeks ago - Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management - GlobeNewsWire
- 7 weeks ago - Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter - GlobeNewsWire
- 7 weeks ago - Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company - GlobeNewsWire
- 2 months ago - Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - GlobeNewsWire